GRAPHJET TECHNOLOGY (GTIJF): Nasdaq/NYSE listing notice — Graphjet Technology regains Nasdaq compliance; subject to one-year Mandatory Panel Monitor

GRAPHJET TECHNOLOGY

Received Nasdaq notice on Sept 24, 2025 confirming compliance with periodic filing and bid price rules.
Subject to one-year Mandatory Panel Monitor; future periodic filing default leads to delist notice without compliance plan.
Company may request a new Nasdaq hearing if delist determination is issued during monitoring period.
No financial data; this is a listing compliance status update.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

GRAPHJET TECHNOLOGY received a nasdaq compliance regained notice regarding late filing (rules 5250(c)(1), 5450(a)(1)).

Exchange: nasdaq
Notice: compliance regained
Deficiency: late filing
Rules: 5250(c)(1), 5450(a)(1)

Exact text from the filing

September 24, 2025, the Company received a written notice (the “ Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”) indicating the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires all listed companies to timely file all required period financial reports with U.S. Securities and Exchange Commission (the “ Periodic Filing Rule ”), and Nasdaq Listing Rule 5450(a)(1), which requires listed companies to maintain a minimum bid price of at least $1.00 per share for their primary equity security to remain listed (the “ Bid Price Rule ”), as required by the July

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

GRAPHJET TECHNOLOGY filing history →

Source: SEC EDGAR

accession 0001213900-25-092330

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.